Clinical Trial Update: Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional MR [NA]

View source ↗

Summary

The Cardiovascular Outcomes Assessment trial of the MitraClip percutaneous therapy in heart failure patients with functional mitral regurgitation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Mitral Regurgitation

Snippet

Sponsor: Abbott Medical Devices | Conditions: Mitral Regurgitation, Mitral Valve Regurgitation | NA | Status: COMPLETED